MCH ADVISORY RESEARCHMain site ↗
Financials

Asset Management & Custody Banks

18 companies under coverage.

Coverage

Asset Management & Custody Banks


Equity Research

Corebridge Financial Inc. (CRBG)

BUY. 12-month probability-weighted target $54 (+60% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

CRBGEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +45.0%
Equity Research

T. Rowe Price Group Inc (TROW)

HOLD. 12-month probability-weighted target $111 (+2% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

TROWEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.2%
Equity Research

Federated Investors Inc B (FHI)

HOLD. 12-month probability-weighted target $57 (-8% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

FHIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.9%
Equity Research

Franklin Resources Inc (BEN)

HOLD. 12-month probability-weighted target $33 (-5% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

BENEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.3%
Equity Research

Carlyle Group Inc (CG)

HOLD. 12-month probability-weighted target $44 (-5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.6%
Equity Research

Apollo Global Management LLC Class A (APO)

SELL. 12-month probability-weighted target $113 (-14% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

APOEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -10.6%
Equity Research

SEI Investments Company (SEIC)

HOLD. 12-month probability-weighted target $101 (-7% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

SEICEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.5%
Equity Research

Ameriprise Financial Inc (AMP)

SELL. 12-month probability-weighted target $423 (-24% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

AMPEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -16.2%
Equity Research

Hamilton Lane Inc (HLNE)

SELL. 12-month probability-weighted target $84 (-17% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

HLNEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.1%
Equity Research

BlackRock Inc (BLK)

SELL. 12-month probability-weighted target $930 (-15% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

BLKEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -20.0%
Equity Research

Northern Trust Corporation (NTRS)

HOLD. 12-month probability-weighted target $176 (-5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

NTRSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -20.5%
Equity Research

Blackstone Group Inc (BX)

SELL. 12-month probability-weighted target $115 (-14% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

BXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.6%
Equity Research

Invesco Plc (IVZ)

SELL. 12-month probability-weighted target $26 (-19% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

IVZEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -22.0%
Equity Research

State Street Corp (STT)

SELL. 12-month probability-weighted target $169 (-12% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

STTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -24.0%
Equity Research

The Bank of New York Mellon Corporation (BNY)

SELL. 12-month probability-weighted target $141 (-13% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

BNYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.2%
Equity Research

Affiliated Managers Group, Inc. (AMG)

SELL. 12-month probability-weighted target $282 (-22% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

AMGEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.9%
Equity Research

KKR & Co. Inc. (KKR)

SELL. 12-month probability-weighted target $88 (-17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

KKREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -39.0%
Equity Research

Ares Management LP (ARES)

SELL. 12-month probability-weighted target $105 (-24% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

ARESEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -40.5%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed